FILINGS
| ALNY 0001178670 | |||
|---|---|---|---|
| Filing Date | Form Type | Description | Document |
| 2017-06-06 | 8-K | FORM 8-K | View Document |
| 2017-06-01 | 4 | FORM 4 SUBMISSION | View Document |
| 2017-05-31 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-05-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-05-25 | 424B5 | 424B5 | View Document |
| 2017-05-25 | 8-K | 8-K | View Document |
| 2017-05-23 | 424B5 | 424B5 | View Document |
| 2017-05-17 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-05-17 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-05-09 | 3 | PRIMARY DOCUMENT | View Document |
| 2017-05-09 | 8-K | FORM 8-K | View Document |
| 2017-05-05 | S-3ASR | S-3ASR | View Document |
| 2017-05-05 | 10-Q | 10-Q | View Document |
| 2017-05-05 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 2017-03-17 | DEF 14A | DEFINITIVE PROXY STATEMENT | View Document |
| 2017-02-15 | 10-K | 10-K | View Document |
| 2017-02-14 | SC 13G/A | SCHEDULE 13G AMENDMENT NO. 1 | View Document |
| 2017-02-14 | SC 13G/A | View Document | |
| 2017-02-13 | SC 13G/A | SC 13G/A | View Document |
| 2017-02-13 | SC 13G/A | View Document | |
| 2017-02-09 | SC 13G/A | SEC SCHEDULE 13G | View Document |
| 2017-02-09 | SC 13G/A | View Document | |
| 2017-02-08 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 2017-02-07 | CT ORDER | View Document | |
| 2017-02-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-01-30 | SC 13G | View Document | |
| 2017-01-27 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-01-20 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-01-06 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-01-04 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-01-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2017-01-03 | 8-K | 8-K | View Document |
| 2016-12-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-12-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-12-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-12-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-12-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-12-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-12-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-12-14 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-12-09 | SC 13G | SCHEDULE 13G | View Document |
| 2016-12-09 | SC 13G/A | View Document | |
| 2016-12-05 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-12-02 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-11-03 | 10-Q | FORM 10-Q | View Document |
| 2016-11-02 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 2016-10-14 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-10-14 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-10-05 | 8-K | 8-K | View Document |
| 2016-09-21 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-09-21 | 3 | PRIMARY DOCUMENT | View Document |
| 2016-09-19 | 8-K | FORM 8-K | View Document |
| 2016-08-04 | 10-Q | FORM 10-Q | View Document |
| 2016-08-04 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 2016-07-21 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-06-15 | 8-K | FORM 8-K | View Document |
| 2016-06-07 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-06-07 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-06-07 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-06-07 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-06-07 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-06-07 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-06-07 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-06-07 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-06-07 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-06-07 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-05-19 | CT ORDER | View Document | |
| 2016-05-06 | 8-K | FORM 8-K | View Document |
| 2016-05-04 | 10-Q | 10-Q | View Document |
| 2016-05-02 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 2016-04-21 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-04-08 | 8-K | FORM 8-K | View Document |
| 2016-04-04 | CT ORDER | View Document | |
| 2016-03-28 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-03-17 | DEF 14A | DEF 14A | View Document |
| 2016-03-10 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-03-09 | CT ORDER | View Document | |
| 2016-03-01 | SC 13G/A | SCHEDULE 13G/A | View Document |
| 2016-02-25 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-02-24 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-02-24 | 4 | FORM 4 SUBMISSION | View Document |
| 2016-02-12 | SC 13G/A | SC 13G/A | View Document |
| 2016-02-12 | 10-K | FORM 10-K | View Document |
| 2016-02-12 | SC 13G/A | View Document | |
| 2016-02-11 | 8-K | ALNYLAM PHARMACEUTICALS, INC. 8-K | View Document |
| 2016-02-11 | SC 13G/A | SEC SCHEDULE 13G | View Document |
| 2016-02-10 | SC 13G | View Document | |
| 2016-02-09 | SC 13G/A | View Document | |
| 2016-02-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-02-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-02-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-02-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-02-03 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-02-03 | 4 | FORM 4 SUBMISSION | View Document |
| 2016-01-28 | SC 13G | View Document | |
| 2016-01-21 | 4 | PRIMARY DOCUMENT | View Document |
| 2016-01-11 | 8-K | 8-K | View Document |
| 2015-12-23 | UPLOAD | View Document | |
| 2015-12-22 | 4 | PRIMARY DOCUMENT | View Document |
| 2015-12-22 | 4 | PRIMARY DOCUMENT | View Document |
Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.
